Elizabeth Arden, Inc. (RDEN) Tops Q2 EPS by 3c, Offers Q3 Outlook and Reaffirms FY12
Tweet
Share
E-mailGet Alerts RDEN Hot Sheet
Price: $13.98 --0%
Financial Fact:
Total cost of goods sold: 99.34M
Today's EPS Names:
BTTX, VAXX, ELYS, More
Financial Fact:
Total cost of goods sold: 99.34M
Today's EPS Names:
BTTX, VAXX, ELYS, More
Join SI Premium – FREE
Elizabeth Arden, Inc. (NASDAQ: RDEN) reported Q2 EPS of $1.42, $0.03 better than the analyst estimate of $1.39. Revenue for the quarter came in at $429.9 million versus the consensus estimate of $428.89 million.
Elizabeth Arden, Inc. reaffirmed FY2012 guidance.
Elizabeth Arden, Inc. sees Q3 2012 EPS of $0.00-$0.04, versus the consensus of $0.06. Elizabeth Arden, Inc. sees Q3 2012 revenue of $238-$243 million, versus the consensus of $243.45 million.
For earnings history and earnings-related data on Elizabeth Arden, Inc. (RDEN) click here.
Elizabeth Arden, Inc. reaffirmed FY2012 guidance.
Elizabeth Arden, Inc. sees Q3 2012 EPS of $0.00-$0.04, versus the consensus of $0.06. Elizabeth Arden, Inc. sees Q3 2012 revenue of $238-$243 million, versus the consensus of $243.45 million.
For earnings history and earnings-related data on Elizabeth Arden, Inc. (RDEN) click here.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- Walmart (WMT) PT Lowered to $130 at UBS on Investment Narrative's Competing Dynamics
- UBS says bull market has further to run
- CoStar Group acquires Zonda for $800M, adding new home data
Create E-mail Alert Related Categories
Earnings, GuidanceRelated Entities
EarningsSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
